NCT05137262 2026-02-18A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the BladderM.D. Anderson Cancer CenterPhase 2 Active not recruiting12 enrolled